Ludwig Hantson
CIK: 0001491435
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jul 15, 2026IONS
IONIS PHARMACEUTICALS INC
Award(A)DirectRestricted Stock Unit
3.4K shares- - Jun 4, 2026IONS
IONIS PHARMACEUTICALS INC
Award(A)DirectNon-Qualified Stock Option (right to buy)
10.8K shares- - Apr 7, 2026HOLX
HOLOGIC INC
Disposition(D)Direct16.1K shares- - Feb 26, 2026HOLX
HOLOGIC INC
Award(A)Direct3.2K shares- - Feb 26, 2025HOLX
HOLOGIC INC
Award(A)Direct1.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 15, 2026 |  IONS IONIS PHARMACEUTICALS INC | Award(A) Restricted Stock Unit | 3,399 | - | - | Direct |
| Jun 4, 2026 | IONS IONIS PHARMACEUTICALS INC | Award(A) Non-Qualified Stock Option (right to buy) | 10,753 | - | - | Direct |
| Apr 7, 2026 |  HOLX HOLOGIC INC | Disposition(D) | 16,146 | - | $0 | Direct |
| Feb 26, 2026 | HOLX HOLOGIC INC | Award(A) | 3,190 | - | $0 | Direct |
| Feb 26, 2025 | HOLX HOLOGIC INC | Award(A) | 1,864 | - | - | Direct |
1-5 of 5 transactions
About HANTSON LUDWIG
HANTSON LUDWIG (SEC CIK 0001491435) files insider reports with the SEC as Director of IONIS PHARMACEUTICALS INC (IONS) and Director of HOLOGIC INC (HOLX).
Signal8 holds 6 ownership filings by HANTSON LUDWIG (1 Form 3, 5 Form 4), filed between Feb 28, 2025 and Jul 17, 2026. Those filings report 5 transactions, from Feb 26, 2025 to Jul 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on HANTSON LUDWIG's filings is in CARLSBAD, CA.
Recent filings by HANTSON LUDWIG
- Jul 15, 2026: Grant or award of IONS derivative securities (Form 4, code A).
- Jun 4, 2026: Grant or award of IONS derivative securities (Form 4, code A).
- Apr 7, 2026: Disposition to issuer transaction of HOLX shares (Form 4, code D).
- Feb 26, 2026: Grant or award of HOLX shares (Form 4, code A).
- Feb 26, 2025: Grant or award of HOLX shares (Form 4, code A).
Other insiders filing for IONIS PHARMACEUTICALS INC (IONS)
- Devers Shannon L., EVP, Chief Human Resources Ofc
- Swayze Eric, EVP Research
- BENNETT C FRANK, EVP, Chief Scientific Officer
- O'NEIL PATRICK R., EVP CLO & General Counsel
- Monia Brett P, Chief Executive Officer
- Birchler Brian, EVP, Corp and Development Ops